Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning (Companion Faculty Lecture)

34:03
 
Share
 

Manage episode 522516835 series 1464352
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Featuring a slide presentation and related discussion from Dr Matthew Lunning, including the following topics:

  • Overview of available chimeric antigen receptor (CAR) T-cell therapies (0:00)
  • Toxicities associated with CAR T-cell therapy (4:03)
  • Mitigation strategies for adverse events (22:02)
  • Novel strategies for outpatient infusion (26:34)
  • Changes to the CAR T-cell therapy safety regulations (30:23)

CME information and select publications

  continue reading

874 episodes

Artwork
iconShare
 
Manage episode 522516835 series 1464352
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Featuring a slide presentation and related discussion from Dr Matthew Lunning, including the following topics:

  • Overview of available chimeric antigen receptor (CAR) T-cell therapies (0:00)
  • Toxicities associated with CAR T-cell therapy (4:03)
  • Mitigation strategies for adverse events (22:02)
  • Novel strategies for outpatient infusion (26:34)
  • Changes to the CAR T-cell therapy safety regulations (30:23)

CME information and select publications

  continue reading

874 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play